Form 4: Jazz Pharmaceuticals SVP, Chief Accounting Officer Patricia Carr Sells Shares to Cover Tax Obligations

Patricia Carr, SVP, Chief Accounting Officer of Jazz Pharmaceuticals plc, sold shares of the company's ordinary stock on March 6th and 7th, 2024, to satisfy tax obligations arising from vesting restricted stock units.

Summary

• Patricia Carr, the SVP, Chief Accounting Officer of Jazz Pharmaceuticals plc, sold shares of the company's ordinary stock on March 6th and 7th, 2024.
• The sales were executed to cover tax obligations related to the vesting of previously granted restricted stock units.
• On March 6th, 1,236 shares were sold at $120.85 per share, and 700 shares were sold at $117.51 per share.
• On March 7th, 1,768 shares were sold at a weighted average price of $116.98, with prices ranging from $116.93 to $117.00.
• Following these transactions, Carr directly owns 6,596 ordinary shares of Jazz Pharmaceuticals plc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock sales by an officer to cover tax obligations. It doesn't inherently convey positive or negative sentiment.

Industry Context

Insider sales are a common occurrence and are often related to personal financial planning or tax obligations. The filing provides transparency into the transactions of company insiders.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates